i
Take the 2-minute quiz
Tell us what your gut's been doing and what you've already tried. No clinic visit; labs recommended, never required.
~2 minLongevity, built around you.Licensed US clinicians·Third-party tested·LegitScript-certified
Gut-Repair Peptides · Live Status
For the gut issues nobody’s solved. The peptides under review for gut repair.
BPC-157 and KPV are the gut-repair peptides people keep asking about. Here's the honest status, what the evidence does and doesn't show, and a notify-me for the moment they're legitimately available.
LegitScript CertifiedThird-Party Batch TestedUS-Licensed CliniciansLive FDA Tracker
An underserved micro-segment, told the truth, not sold a research vial.
The transparent operator. Status you can verify, sourcing you can trust.
Third-party batch-testedUS-licensed cliniciansLegitScript-certifiedLive FDA status
LegitScript
Certified
Certified
Third-Party
Batch Tested
Batch Tested
US-Licensed
Clinicians
Clinicians
Live FDA
Peptide Tracker
Peptide Tracker
20,000+ licensed clinicians · 50-state coverage.
Why sourcing is the whole game
The molecule is easy to find. The safe version isn’t.
Most peptides online ship under a “research use only: not for human consumption” label. That one phrase lets a seller skip FDA oversight, sterility testing, and any real manufacturing standard, and hands the entire risk to you.
What you’re not getting here
- No research-chemical vials.
- No “not for human use” labels.
- No anonymous overseas seller.
- A clinician, a licensed pharmacy, and a test result you can actually see.
The Peptós.LIFE lane
Prescribed by a US-licensed clinician. Compounded in a US-licensed 503A/503B pharmacy to USP sterility and potency standards. Third-party tested every batch: identity, potency, and sterility. Monitored as an actual clinical relationship, not a one-time sale.
Compounded medications are not FDA-approved. Where that applies, we say so. Status and timelines are tracked openly on our FDA Tracker.
See exactly where every compound standsIs this you?
You're here because the gut stuff never really got solved.
Gut issues conventional care hasn't resolved, and you've run out of easy answers.
You've read that BPC-157 is the gut-repair peptide, and want the real status.
You want it from a clinician and a licensed pharmacy, not an anonymous research-chem seller.
You'd rather hear the honest version of the evidence than a hype reel.
The pair people ask about
BPC-157 and KPV, the gut-repair pair.
Two peptides people pair for the gut. Here's what each is, in plain English, no doses, no protocols, that's a clinician's call, not a web page's.
The gut-lining signal
BPC-157
A 15-amino-acid peptide derived from a protein found in gastric juice, studied in the hope of supporting the gut lining as well as tendon, joint, and muscle tissue.
The anti-inflammatory signal
KPV
A short α-MSH-derived tripeptide studied in preclinical models for calming NF-κB inflammation, the gut-leaning member of the pair.
The pair people reach for when the interest is the gut as much as the joints. Both are under FDA review, and the combination has never been tested in people.
Where they actually stand
The honest status of the gut-repair peptides, today.
Under PCAC reviewWaitlist / coming
BPC-157 + KPV
BPC-157 and KPV are both among the seven peptides under FDA review, and both are on the PCAC agenda for July 23, 2026. The meeting is advisory, not authorization. Neither is available to prescribe today, and we won't pretend otherwise. Join the list and we'll tell you the moment either is legitimately available.
Next FDA actionFDA PCAC \u00b7 July 23\u201324, 2026
See the live FDA Tracker Advisory, not authorization, and reclassification is not the same as FDA approval. See each on the live Tracker: BPC-157 and KPV.
How it works
Async by design. A clinician, not a checkout.
ii
A US-licensed clinician reviews
A real, named clinician reads your case and maps what's legitimately available, and flags you for the waitlist on what isn't yet.
~24 hrsiii
Join the status list
BPC-157 and KPV aren't available to prescribe yet, and we won't pretend otherwise. Join the list and we'll tell you the moment either is legitimately available.
WaitlistThe honest evidence
What they are, and what we still don't know.
The part most sites skip is the part that matters most for your gut. We describe what each is used in the hope of, never what it treats, and we won't make a gut claim the evidence hasn't earned.
What they are
BPC-157 is a gastric-juice-derived peptide taken in the hope of supporting the gut lining and soft tissue; KPV is an α-MSH-derived tripeptide studied for calming inflammation. People reach for them for stubborn gut issues, and the marketing runs far louder than the science.
What we still don't know
Both are evidence grade D: animal-dominant, with no placebo-controlled human efficacy trials for gut conditions, and no combination data. We don't claim either treats IBS, reflux, or “leaky gut”, because the evidence doesn't support that, and saying so is the point.
Your gut interest often overlaps with a metabolic plan, and that base is available today. Want something now while the peptides clear review?
Questions
The honest answers.
We can't claim that, and we won't. Both are studied in the hope of supporting the gut lining and calming inflammation, but the evidence is early (grade D, animal-dominant) and neither is available to prescribe today. We describe what they're studied for, not what they treat.
Neither is available to prescribe today. Both were removed from FDA compounding Category 2 and both are on the FDA's PCAC agenda for July 23, 2026, which is advisory, not authorization. “Removed from one list” is not the same as “legal to compound” or “available.” We track the real status on the live FDA Peptide Tracker.
Not from us. They're not yet available to prescribe, and we won't sell something we can't stand behind, especially not a research-chemical vial. Join the waitlist and you'll be first to know the moment either is legitimately available, sourced through a licensed pharmacy and batch-tested.
We won't overpromise a peptide that's under review. If a metabolic plan fits your goals, that base is available today through a licensed clinician, and many people with gut concerns start there. Take the quiz and a clinician maps what's legitimately available to where you actually are.
No. Compounded medications are not FDA-approved; they're prepared by a licensed pharmacy for an individual patient when a clinician determines they're appropriate. BPC-157 and KPV aren't even at that stage yet, they're under review. Compounded, not FDA-approved, said out loud.
Get notified
Be first in line, the honest way.
Join the status list. We'll notify you the moment BPC-157 or KPV is legitimately available, and keep you posted on the FDA review in plain English.
The FDA's advisory committee reviews BPC-157 and KPV on July 23\u201324, 2026. Join the list to get the outcome in plain English the day it lands, and your place in line if either clears. (Advisory only; not an approval or a launch date.)
No charge. No spam. Just the status, and your spot at the front of the line. By joining you agree to receive email and SMS updates; opt out anytime. Compounded medications are not FDA-approved.
Want something available now? See the metabolic base Read the honest BPC-157 monograph